mRNA

Zhaodan Xin1, Hao Chen1, Jingtong Xu2

  • 1Department of Laboratory Medicine, West China Hospital, Sichuan University, Chengdu, China.

概括

血外体PRPSAP1mRNA显示了在手术前在肝细胞癌 (HCC) 患者中进行微血管入侵 (MVI) 的非侵入性预测的潜力. 这种生物标志物可能有助于识别MVI患者.